Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Phase I clinical trial
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Mesenchymal stem cells
Phase I clinical trial
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
EXO-CD24
Phase I clinical trial
Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022
Nirmatrelvir
Phase I clinical trial
Emergency use authorization Experimental Antiviral Jun/23/2022
Ad26.COV2.S
Phase I clinical trial
Emergency use authorization Experimental Vaccine Jun/22/2022
BNT162b2
Phase I clinical trial
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Phase I clinical trial
Emergency use authorization Experimental Vaccine Jun/22/2022
Cilgavimab
Phase I clinical trial
Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
Phase I clinical trial
Emergency use authorization Experimental Antiviral Jun/18/2022
REGEN-COV
Phase I clinical trial
Emergency use authorization Experimental Antiviral Jun/03/2022
Ivermectin
Phase I clinical trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
ChAdOx1 nCoV-19
Phase I clinical trial
Emergency use authorization Experimental Vaccine Jan/04/2022
BBIBP-CorV
Phase I clinical trial
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
Gam-COVID-Vac
Phase I clinical trial
Emergency use authorization Experimental Vaccine Dec/23/2021
Ritonavir
Phase I clinical trial
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
NVX-CoV2373
Phase I clinical trial
Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021
Niclosamide
Phase I clinical trial
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
CoronaVac
Phase I clinical trial
Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021
BBV152
Phase I clinical trial
Emergency use authorization Experimental Vaccine Mar/27/2021
Ribavirin
Phase I clinical trial
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021